Clinical trial · Interventional
Agreement Between Oral and Cervical Human Papillomavirus Infection in a French Cohort
Agreement Between Oral and Cervical Human Papillomavirus Infection in a French Cohort of Women Infected With Cervical HPV
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Human papillomaviruses (HPVs) are the most common of sexually transmitted viral agents and they are associated with genital and oral diseases. Agreement between cervical and oral HPV infection has been described from a small group of patient. Our study, performed on a greater number of patients, will provide a good estimation of this link, between cervical and oral infection, in a French population of women with a primary cervical HPV infection.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Human Papillomavirus-Related Cervical Carcinoma | Human Papillomavirus-Related Cervical Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Agreement between oral and cervical HPV infection | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Experimental arm
- interventionNames
- Other: Agreement between oral and cervical HPV infection
Primary outcomes (1)
- measure
- Agreement between oral and cervical HPV infection
- timeFrame
- up to 6 months
- description
- Agreement between oral and cervical HPV infection is defined by the presence of at least one identical genotype HPV in both sites in the same wife. All genotypes found in the oral and cervical area will be considered.
Secondary outcomes (7)
- measure
- Agreement between full and partial oral and cervical HPV genotypes
- timeFrame
- up to 6 months
- description
- Agreement between oral and cervical HPV genotypes is considered as complete if the same HPV genotypes were detected on both sites. Agreement between oral and cervical HPV genotypes is considered as partial when at least one but not all HPV genotypes were detected at both sites.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histologic proven of cervical intraepithelial neoplasia or carcinoma in situ (CIS) or invasive cervical cancer or a Pap smear on which at least one HPV has been detected * Patients not vaccinated against HPV * Age \>18 years * EOCG performance status ≤ 3 * Patient must be affiliated to a social security system * Ability to provide written informed consent patient's legal capacity to consent to study participation and to understand and comply with the requirements of the study Exclusion Criteria: * Patients vaccinated against HPV * Pregnant woman over 10 weeks * Patient who underwent head and neck radiotherapy dating less than one year * Patients deprived of liberty or under supervision
References
Publications (0)
Data not yet available